0,934  0,002  Dopamine D1 antagonist
0,871  0,002  Dopamine D2 agonist
0,839  0,003  Dopamine agonist
0,819  0,003  5 Hydroxytryptamine release stimulant
0,794  0,004  UGT1A9 substrate
0,760  0,004  Dopamine antagonist
0,754  0,002  Dopamine D5 antagonist
0,751  0,002  Tyrosine 3 hydroxylase inhibitor
0,751  0,003  5 Hydroxytryptamine 7 antagonist
0,727  0,004  Dopamine D2 antagonist
0,716  0,007  Antiparkinsonian
0,696  0,004  Muscle relaxant
0,672  0,004  Skeletal muscle relaxant
0,675  0,012  Respiratory analeptic
0,662  0,003  Alpha 2a adrenoreceptor antagonist
0,662  0,012  Aldehyde oxidase inhibitor
0,657  0,008  Spasmolytic
0,648  0,003  Pneumotoxic
0,666  0,028  Caspase 9 stimulant
0,640  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,609  0,003  Alpha 2b adrenoreceptor antagonist
0,610  0,007  Cardiodepressant
0,610  0,015  Vasodilator, peripheral
0,590  0,004  Alpha 2 adrenoreceptor antagonist
0,606  0,030  Transcription factor NF kappa B inhibitor
0,573  0,005  UGT1A3 substrate
0,568  0,005  Sigma receptor agonist
0,566  0,006  Sedative
0,563  0,005  Alpha adrenoreceptor antagonist
0,548  0,020  CYP2C19 substrate
0,531  0,005  Cyclic AMP phosphodiesterase inhibitor
0,542  0,018  Analeptic
0,524  0,004  Alpha 2c adrenoreceptor antagonist
0,513  0,004  Antitussive
0,537  0,039  Antineoplastic (lung cancer)
0,552  0,060  Apoptosis agonist
0,526  0,036  CYP3A4 substrate
0,510  0,023  CYP2D6 substrate
0,513  0,030  Prostate cancer treatment
0,487  0,006  Calcium channel activator
0,491  0,012  Antineoplastic enhancer
0,497  0,028  Antidepressant
0,488  0,024  Cardioprotectant
0,464  0,006  5 Hydroxytryptamine 2B antagonist
0,461  0,005  5 Hydroxytryptamine 1A antagonist
0,488  0,037  Antineoplastic (colorectal cancer)
0,479  0,030  CYP2C19 inhibitor
0,454  0,008  5 Hydroxytryptamine 2 antagonist
0,479  0,036  Antineoplastic (colon cancer)
0,497  0,055  Antineoplastic (breast cancer)
0,459  0,019  Antipyretic
0,443  0,005  5 Hydroxytryptamine 1 antagonist
0,438  0,004  Dopamine D3 antagonist
0,455  0,023  CYP2D6 inhibitor
0,474  0,044  Antileukemic
0,464  0,037  Mood disorders treatment
0,444  0,017  Vasodilator
0,458  0,032  Antipsychotic
0,431  0,005  Toxic, respiratory center
0,468  0,043  CYP2C9 substrate
0,430  0,009  Male reproductive disfunction treatment
0,426  0,006  Alpha 1 adrenoreceptor antagonist
0,424  0,010  Tubulin antagonist
0,420  0,008  Antialcoholic
0,413  0,010  5 Hydroxytryptamine antagonist
0,453  0,053  15-Lipoxygenase inhibitor
0,402  0,002  Prolactin inhibitor
0,449  0,051  Histamine release inhibitor
0,430  0,034  CYP1A2 substrate
0,415  0,021  Dependence treatment
0,393  0,005  Dopamine D4 antagonist
0,400  0,015  Antiparkinsonian, rigidity relieving
0,392  0,007  5 Hydroxytryptamine 2A antagonist
0,394  0,012  UGT2B7 substrate
0,393  0,018  UGT1A1 substrate
0,398  0,023  Antimitotic
0,399  0,031  UGT2B4 substrate
0,370  0,004  5 Hydroxytryptamine 5A antagonist
0,370  0,004  Opioid kappa receptor antagonist
0,373  0,009  Erectile dysfunction treatment
0,385  0,023  FMO3 substrate
0,365  0,005  5 Hydroxytryptamine 1F antagonist
0,371  0,019  UGT1A4 substrate
0,359  0,008  Acetylcholine M1 receptor antagonist
0,346  0,002  Dopamine D1 agonist
0,345  0,004  5 Hydroxytryptamine 5 antagonist
0,350  0,010  5 Hydroxytryptamine 1E antagonist
0,364  0,024  UDP-glucuronosyltransferase substrate
0,359  0,020  P-glycoprotein inhibitor
0,371  0,034  Free radical scavenger
0,411  0,074  TNF expression inhibitor
0,348  0,014  Cholinergic
0,344  0,016  Antineoplastic (squamous cell carcinoma)
0,335  0,008  Alpha 1a adrenoreceptor antagonist
0,334  0,011  Antiadrenergic
0,327  0,005  LDLR expression enhancer
0,353  0,031  Psychostimulant
0,348  0,038  Tumour necrosis factor alpha release inhibitor
0,318  0,013  Antidote
0,316  0,012  Adrenaline antagonist
0,345  0,043  Sodium/bile acid cotransporter inhibitor
0,348  0,051  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,338  0,042  Antiamyloidogenic
0,323  0,028  Anesthetic general
0,302  0,010  UGT2B9 substrate
0,325  0,034  5 Hydroxytryptamine uptake stimulant
0,298  0,007  Acetylcholine nicotinic antagonist
0,325  0,038  UGT1A6 substrate
0,295  0,009  Expectorant
0,338  0,054  Antihypercholesterolemic
0,330  0,047  Antihypoxic
0,334  0,051  Antioxidant
0,297  0,015  Cholinergic antagonist
0,296  0,014  Antidiarrheal
0,294  0,014  Acetylcholinesterase inhibitor
0,293  0,014  Acetylcholine antagonist
0,296  0,018  Antiparkinsonian, tremor relieving
0,294  0,017  Genotoxic
0,372  0,097  Analgesic
0,280  0,006  Sigma receptor antagonist
0,312  0,048  Flavin-containing monooxygenase substrate
0,269  0,009  UGT2B10 substrate
0,273  0,014  Cocaine dependence treatment
0,342  0,086  Ulceration
0,327  0,073  Antithrombotic
0,271  0,017  M18 aspartyl aminopeptidase inhibitor
0,335  0,085  Stroke treatment
0,256  0,008  Constipation treatment
0,254  0,008  Opioid antagonist
0,316  0,071  Caspase 3 stimulant
0,249  0,005  Antineoplastic alkaloid
0,266  0,023  UGT2B15 substrate
0,275  0,034  Antimigraine
0,265  0,027  Antiseptic
0,281  0,043  Antiarrhythmic
0,273  0,037  Hepatoprotectant
0,244  0,011  Alpha 1b adrenoreceptor antagonist
0,249  0,017  Neuropathy treatment
0,246  0,015  VEGF expression inhibitor
0,230  0,005  Myasthenia Gravis treatment
0,358  0,133  Antineoplastic (solid tumors)
0,229  0,006  Opioid mu receptor antagonist
0,225  0,004  Restless leg syndrome treatment
0,295  0,075  Antineoplastic (ovarian cancer)
0,228  0,007  Neuronal nicotinic receptor antagonist
0,283  0,064  Antineoplastic (non-small cell lung cancer)
0,288  0,072  Radioprotector
0,272  0,055  Pyruvate kinase inhibitor
0,246  0,031  Antineoplastic (gastric cancer)
0,237  0,023  Anesthetic local
0,294  0,083  12-Lipoxygenase inhibitor
0,310  0,099  Cognition disorders treatment
0,224  0,014  5 Hydroxytryptamine 2C antagonist
0,277  0,067  DNA damaging
0,291  0,085  CYP3A4 inhibitor
0,212  0,009  Opioid delta receptor antagonist
0,226  0,024  Uterine stimulant
0,233  0,030  Lipid peroxidase inhibitor
0,209  0,008  Alpha adrenoreceptor agonist
0,210  0,009  Alpha 1d adrenoreceptor antagonist
0,288  0,088  Hepatic disorders treatment
0,233  0,035  Antineoplastic (carcinoma)
0,264  0,068  NOS2 expression inhibitor
0,246  0,050  DNA methylase inhibitor
0,202  0,007  Beta tubulin antagonist
0,203  0,009  Analgesic, opioid
0,244  0,055  Mutagenic
0,211  0,023  Alkylator
0,259  0,073  Teratogen
0,280  0,095  AR expression inhibitor
0,327  0,143  Alzheimer's disease treatment
0,187  0,005  Opioid mu receptor agonist
0,225  0,046  Antimutagenic
0,251  0,072  Antineoplastic (liver cancer)
0,249  0,075  Superoxide dismutase inhibitor
0,293  0,119  Immunosuppressant
0,184  0,011  Antiviral (Papilloma)
0,178  0,005  Alpha 2 adrenoreceptor agonist
0,248  0,076  Antineoplastic (cervical cancer)
0,208  0,038  Aldehyde oxidase substrate
0,195  0,026  Acetylcholine muscarinic antagonist
0,200  0,030  Toll-Like receptor antagonist
0,193  0,026  Cystathionine beta-synthase inhibitor
0,170  0,004  Narcotic antagonist
0,238  0,073  Cytostatic
0,179  0,015  AMP-activated protein kinase stimulant
0,255  0,091  Antineoplastic (melanoma)
0,249  0,086  Radiosensitizer
0,220  0,059  Neurotrophic factor enhancer
0,165  0,005  Opioid kappa receptor agonist
0,288  0,129  Antipruritic, allergic
0,231  0,071  Antihypotensive
0,272  0,113  Vasodilator, coronary
0,199  0,040  Anesthetic
0,166  0,008  Alpha 1 adrenoreceptor agonist
0,174  0,021  UGT2B1 substrate
0,158  0,007  Opioid agonist
0,177  0,029  Antiprotozoal (Amoeba)
0,157  0,011  Tocolytic
0,149  0,004  5 Hydroxytryptamine 7 agonist
0,155  0,012  5 Hydroxytryptamine 1B antagonist
0,152  0,009  Alpha tubulin antagonist
0,154  0,011  5 Hydroxytryptamine 1D antagonist
0,140  0,003  Prolactin release inhibitor
0,201  0,067  Nitric oxide antagonist
0,250  0,117  Antineoplastic (osteosarcoma)
0,161  0,028  Choleretic
0,223  0,089  Cardiovascular analeptic
0,216  0,085  Embryotoxic
0,298  0,168  5 Hydroxytryptamine release inhibitor
0,179  0,050  Protein kinase stimulant
0,179  0,052  Antiischemic, cerebral
0,222  0,096  Antineoplastic (sarcoma)
0,214  0,091  Antineoplastic (glioma)
0,168  0,045  NADPH oxidase inhibitor
0,130  0,008  Nicotinic receptor alpha7 subunit antagonist
0,228  0,107  Antineoplastic (pancreatic cancer)
0,198  0,079  Cytotoxic
0,138  0,021  UGT2B11 substrate
0,122  0,007  5 Hydroxytryptamine 2 agonist
0,230  0,116  Anxiolytic
0,205  0,093  RNA-directed DNA polymerase inhibitor
0,220  0,109  Antineoplastic (bladder cancer)
0,138  0,027  Calcium antagonist
0,242  0,131  Prostaglandin dehydrogenase inhibitor
0,190  0,079  Abortion inducer
0,153  0,043  Antismoking
0,213  0,109  Proliferative diseases treatment
0,134  0,031  Toll-Like receptor 4 antagonist
0,106  0,005  Sigma 2 receptor antagonist
0,186  0,086  Amyloid beta aggregation inhibitor
0,137  0,038  Nav1.1 sodium channel blocker
0,110  0,011  5 Hydroxytryptamine 2A agonist
0,230  0,132  CTGF expression inhibitor
0,160  0,064  NOS3 expression enhancer
0,182  0,090  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,131  0,039  Bronchodilator
0,119  0,028  Phosphodiesterase I inhibitor
0,133  0,042  Protein kinase C gamma inhibitor
0,199  0,109  Acute neurologic disorders treatment
0,112  0,022  Nicotinic alpha4beta2 receptor antagonist
0,131  0,042  Butyrylcholinesterase inhibitor
0,208  0,120  Amyotrophic lateral sclerosis treatment
0,183  0,096  Antihypertriglyceridemic
0,149  0,064  Amylase inhibitor
0,118  0,034  Protein kinase C zeta inhibitor
0,124  0,042  Electron transport complex I inhibitor
0,104  0,023  HIV-1 integrase inhibitor
0,096  0,015  Uterine relaxant
0,090  0,009  5 Hydroxytryptamine 1B agonist
0,096  0,016  5 Hydroxytryptamine 6 antagonist
0,089  0,009  5 Hydroxytryptamine 4 antagonist
0,170  0,090  Sensitization
0,136  0,057  Topoisomerase II inhibitor
0,230  0,152  FMO1 substrate
0,083  0,005  Dopamine D5 agonist
0,137  0,061  Antihelmintic (Trematoda)
0,165  0,090  DNA methyltransferase I inhibitor
0,161  0,087  Tumour necrosis factor antagonist
0,105  0,032  5 Hydroxytryptamine agonist
0,132  0,059  Antineoplastic (uterine cancer)
0,077  0,008  Sigma 1 receptor antagonist
0,112  0,045  Breast cancer-resistant protein inhibitor
0,193  0,126  Cardiotonic
0,189  0,123  Hypoglycemic
0,091  0,025  Female sexual dysfunction treatment
0,075  0,009  Factor III inhibitor
0,111  0,045  Estrogen receptor beta antagonist
0,207  0,142  NOS3 expression inhibitor
0,149  0,084  Carcinogenic, group 1
0,098  0,034  Phosphodiesterase XI inhibitor
0,098  0,034  Phosphodiesterase 11A inhibitor
0,227  0,163  Antiprotozoal (Plasmodium)
0,120  0,056  Estrogen antagonist
0,087  0,023  Dopamine uptake inhibitor
0,099  0,035  Antiprotozoal activity enhancer
0,139  0,076  Ca2+-transporting ATPase inhibitor
0,077  0,014  Nicotinic receptor alpha4 subunit antagonist
0,233  0,171  Antineoplastic (small cell lung cancer)
0,159  0,098  Sleep disorders treatment
0,094  0,035  Histidine decarboxylase inhibitor
0,197  0,138  Chemoprotective
0,128  0,070  Toll-Like receptor 2 antagonist
0,132  0,075  Toll-Like receptor 9 antagonist
0,118  0,062  Microtubule formation inhibitor
0,067  0,012  Dopamine D3 agonist
0,105  0,050  HIV-1 integrase (Overall Integration) inhibitor
0,075  0,021  5 Hydroxytryptamine 1A agonist
0,175  0,123  VCAM1 expression inhibitor
0,113  0,061  Acetylcholine release stimulant
0,089  0,037  Estrogen receptor alpha antagonist
0,161  0,110  Antineoplastic (glioblastoma multiforme)
0,282  0,232  Antiinflammatory
0,196  0,146  Antiischemic
0,082  0,033  HIV-1 integrase (3'-Processing) inhibitor
0,110  0,062  Topoisomerase I inhibitor
0,112  0,064  SULT1A1 substrate
0,066  0,020  Nicotinic alpha3beta2 receptor antagonist
0,069  0,023  Dopamine D4 agonist
0,178  0,132  Vascular (periferal) disease treatment
0,074  0,029  Beta 3 adrenoreceptor antagonist
0,108  0,064  Multidrug resistance-associated protein 1 inhibitor
0,094  0,051  Histamine N-methyltransferase inhibitor
0,075  0,033  HIV-1 integrase (Strand Transfer) inhibitor
0,159  0,118  CYP2B6 inhibitor
0,053  0,012  Opioid delta receptor agonist
0,060  0,019  Nicotinic receptor alpha3 subunit antagonist
0,087  0,047  Estrogen-related receptor beta agonist
0,122  0,086  Antifungal enhancer
0,131  0,095  Chemopreventive
0,097  0,061  Obsessive-compulsive disorder treatment
0,058  0,023  Topoisomerase II beta inhibitor
0,114  0,080  Antiviral (Influenza B)
0,093  0,058  SULT1E1 substrate
0,038  0,004  NMDA receptor phencyclidine site antagonist
0,060  0,025  Dopamine transporter inhibitor
0,071  0,037  Beta adrenoreceptor antagonist
0,054  0,021  Potassium channel small-conductance Ca-activated blocker
0,063  0,031  5 Hydroxytryptamine 1 agonist
0,130  0,098  Heat shock protein 90 antagonist
0,113  0,082  Antifungal (Pneumocystis)
0,062  0,032  Ryanodine receptor antagonist
0,095  0,065  Creatine kinase inhibitor
0,040  0,010  Nicotinic alpha3beta4 receptor agonist
0,046  0,016  5 Hydroxytryptamine 3B antagonist
0,077  0,049  Acetylcholine M4 receptor antagonist
0,061  0,035  Beta 1 adrenoreceptor antagonist
0,044  0,018  Vesicle monoamine transporter inhibitor
0,063  0,038  Acetylcholine M5 receptor antagonist
0,052  0,026  5 Hydroxytryptamine 2C agonist
0,055  0,030  Glucose-6-phosphate translocase inhibitor
0,148  0,124  Phobic disorders treatment
0,083  0,060  mTOR complex 2 inhibitor
0,078  0,056  Antidote, organophosphates
0,061  0,039  Phosphodiesterase 1A inhibitor
0,097  0,077  DNA intercalator
0,099  0,079  Endometrios treatment
0,061  0,041  Phosphodiesterase 1B inhibitor
0,144  0,124  Non-steroidal antiinflammatory agent
0,119  0,099  Psychosexual dysfunction treatment
0,030  0,013  Dopamine autoreceptor agonist
0,092  0,074  Sulfotransferase substrate
0,041  0,024  NMDA receptor subunit 3A antagonist
0,222  0,205  Antibacterial
0,060  0,044  NMDA 2C receptor antagonist
0,040  0,025  5 Hydroxytryptamine 2B agonist
0,097  0,082  DOPA decarboxylase inhibitor
0,035  0,020  Melatonin 2 agonist
0,179  0,165  Lipoxygenase inhibitor
0,050  0,037  Beta 2 adrenoreceptor antagonist
0,115  0,103  Neurotrophic factor
0,065  0,053  Glutamate (mGluR7) antagonist
0,136  0,124  Platelet adhesion inhibitor
0,062  0,051  Calcium channel P-type blocker
0,137  0,126  ATPase inhibitor
0,112  0,102  Antihemorrhagic
0,029  0,019  5 Hydroxytryptamine 6 agonist
0,125  0,116  GABA C receptor rho-2 antagonist
0,119  0,109  SULT1A3 substrate
0,089  0,080  Tourette's syndrome treatment
0,072  0,064  Antineoplastic antibiotic
0,074  0,067  Glycine receptor antagonist
0,056  0,049  Potassium channel (Ca-activated) blocker
0,194  0,187  Apoptosis antagonist
0,027  0,021  Nicotinic alpha4beta2 receptor agonist
0,035  0,029  Nicotinic receptor beta4 subunit antagonist
0,129  0,124  Antipruritic
0,049  0,045  Protein kinase C eta inhibitor
0,078  0,073  CC chemokine 5 receptor agonist
0,058  0,055  Phosphodiesterase 1C inhibitor
0,053  0,051  Androgen agonist
0,064  0,062  SULT2A1 substrate
0,138  0,136  Succinate dehydrogenase inhibitor
0,054  0,052  Heat shock protein 90 beta antagonist
0,040  0,040  Antibiotic Glycopeptide-like

